Background: The first silicone breast implant was inserted in 1962. In 1997, the first case of
anaplastic large cell lymphoma (ALCL) in association with a silicone breast implant was …

Importance Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), a rare
peripheral T-cell lymphoma, is increasing in incidence. However, many practitioners who …

Purpose Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type
of T-cell lymphoma that arises around breast implants. The optimal management of this …

Purpose Breast implant–associated anaplastic large-cell lymphoma (ALCL) is a recently
described clinicopathologic entity that usually presents as an effusion-associated fibrous …

Background ALK-negative anaplastic large cell lymphoma associated with breast implant (i-
ALCL) has been recently recognized as a distinct entity. Among 43 830 lymphomas …

Breast implant-associated anaplastic large cell lymphoma is a newly recognized provisional
entity in the 2017 revision of the World Health Organization Classification of Tumors of …

The goal of this continuing medical education module is to present the assessment of a
patient with suspected breast implant–associated anaplastic large cell lymphoma, the …

Breast implant-associated anaplastic large cell lymphoma (BIA ALCL) is a newly described
clinicopathologic entity. The purpose of this study is to describe the imaging findings of …

The risk of hematological malignancies is mainly determined by genetic background, age,
sex, race and ethnicity, geographic location, exposure to certain chemicals and radiation; …

Peripheral T-cell lymphomas (PTCLs) represent a relatively uncommon heterogeneous
group of non-Hodgkin's lymphomas (NHLs) with an aggressive clinical course and poor …